Skip to main content

Table 2 TB-HIV co-infection management

From: The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational study

TB-HIV co-infected study participants

CD4+ T-cell count: no. (%)

6 (33)

   CD4+ T-cells/μL: median (range)

318 (18-739)

   CD4+ T-cells <200

2

   CD4+ T-cells 200-350

1

   CD4+ T-cells >350

3

   CD4+ T-cells unknown

12

Anti-retroviral therapy: no. (%)

4/18 (22)

   Commenced prior to TB diagnosis

1

   Commenced during TB treatment

1

   Commenced after TB treatment completed

2

ART type

 

   AZT/3TC/nevirapine

3

   AZT/3TC/efavirenz

1

Co-trimoxazole: no. (%)

11/18 (61)